![Eric Karas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Karas
Corporate Officer/Principal at
ARS Subsidiary, Inc.
Net worth: 73 056 $ as of 31/08/2026
Profile
Eric Karas is currently Chief Commercial Officer at ARS Pharmaceuticals Operations, Inc. since 2022.
Formerly, Mr. Karas was Vice President & General Manager-Commercial at Emergent BioSolutions, Inc. from 2018 to 2022.
Mr. Karas also served as Chief Commercial Officer at ARS Pharmaceuticals, Inc. from 2022 to 2026.
Education includes an undergraduate degree from Rutgers State University of New Jersey and an MBA from Eli Broad College of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/06/2026 | 12,176 ( 0.01% ) | 73 056 $ | 31/08/2026 |
Eric Karas active positions
| Companies | Position | Start |
|---|---|---|
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Corporate Officer/Principal | 01/04/2022 |
Former positions of Eric Karas
| Companies | Position | End |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2026 |
| EMERGENT BIOSOLUTIONS INC. | Corporate Officer/Principal | 01/03/2022 |
Training of Eric Karas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
41
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Eli Broad College of Business
 Eli Broad College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Eric Karas
